Melisron
Melisron Ltd. operates as a commercial real estate company in Israel. It operates through Income-Producing Assets and Residential Construction Development segments. The company engages in the purchase, construction, operation, rental, management, maintenance, and improvement of commercial centers, including malls and shopping centers; development, construction, owning, maintenance, and management… Read more
Melisron (MLSR) - Total Liabilities
Latest total liabilities as of September 2025: ILA20.10 Billion ILA
Based on the latest financial reports, Melisron (MLSR) has total liabilities worth ILA20.10 Billion ILA as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Melisron - Total Liabilities Trend (2004–2024)
This chart illustrates how Melisron's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Melisron Competitors by Total Liabilities
The table below lists competitors of Melisron ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
CPN Commercial Growth Leasehold Property Fund
BK:CPNCG
|
Thailand | ฿1.24 Billion |
|
American Tungsten & Antimony Ltd
AU:AT4
|
Australia | AU$536.08K |
|
Cheffelo AB (publ)
F:4HY
|
Germany | €281.83 Million |
|
Viatron Technologies Inc
KQ:141000
|
Korea | ₩23.43 Billion |
|
IL Science Co. Ltd
KQ:307180
|
Korea | ₩125.87 Billion |
|
SDCL EDGE Acquisition Corporation
NYSE:SEDA-UN
|
USA | $110.33 Million |
Liability Composition Analysis (2004–2024)
This chart breaks down Melisron's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.55 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.62 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.61 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Melisron's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Melisron (2004–2024)
The table below shows the annual total liabilities of Melisron from 2004 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ILA18.96 Billion | +17.96% |
| 2023-12-31 | ILA16.07 Billion | +6.06% |
| 2022-12-31 | ILA15.15 Billion | -1.85% |
| 2021-12-31 | ILA15.44 Billion | +11.63% |
| 2020-12-31 | ILA13.83 Billion | -1.21% |
| 2019-12-31 | ILA14.00 Billion | +6.99% |
| 2018-12-31 | ILA13.08 Billion | -2.18% |
| 2017-12-31 | ILA13.38 Billion | +4.67% |
| 2016-12-31 | ILA12.78 Billion | +9.75% |
| 2015-12-31 | ILA11.64 Billion | +1.11% |
| 2014-12-31 | ILA11.52 Billion | -2.11% |
| 2013-12-31 | ILA11.76 Billion | -2.07% |
| 2012-12-31 | ILA12.01 Billion | -1.91% |
| 2011-12-31 | ILA12.25 Billion | +267.61% |
| 2010-12-31 | ILA3.33 Billion | +13.28% |
| 2009-12-31 | ILA2.94 Billion | +122.19% |
| 2008-12-31 | ILA1.32 Billion | +3.00% |
| 2007-12-31 | ILA1.29 Billion | +4.91% |
| 2006-12-31 | ILA1.22 Billion | +77.18% |
| 2005-12-31 | ILA691.38 Million | +207.60% |
| 2004-12-31 | ILA224.77 Million | -- |